Algert Global LLC acquired a new position in Ignyta, Inc. (NASDAQ:RXDX) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 64,433 shares of the biopharmaceutical company’s stock, valued at approximately $667,000.

Other large investors have also recently modified their holdings of the company. State Street Corp raised its stake in shares of Ignyta by 7.8% in the fourth quarter. State Street Corp now owns 426,861 shares of the biopharmaceutical company’s stock worth $2,264,000 after buying an additional 30,833 shares in the last quarter. Renaissance Technologies LLC raised its stake in shares of Ignyta by 2.4% in the fourth quarter. Renaissance Technologies LLC now owns 92,100 shares of the biopharmaceutical company’s stock worth $488,000 after buying an additional 2,200 shares in the last quarter. Wells Fargo & Company MN raised its stake in shares of Ignyta by 4.8% in the first quarter. Wells Fargo & Company MN now owns 21,885 shares of the biopharmaceutical company’s stock worth $188,000 after buying an additional 1,000 shares in the last quarter. TFS Capital LLC raised its stake in shares of Ignyta by 5.5% in the first quarter. TFS Capital LLC now owns 32,486 shares of the biopharmaceutical company’s stock worth $279,000 after buying an additional 1,680 shares in the last quarter. Finally, Trexquant Investment LP purchased a new stake in shares of Ignyta during the first quarter worth $219,000. Institutional investors and hedge funds own 52.96% of the company’s stock.

Shares of Ignyta, Inc. (RXDX) opened at 9.50 on Friday. The company’s 50-day moving average price is $9.86 and its 200-day moving average price is $8.35. Ignyta, Inc. has a 12 month low of $4.15 and a 12 month high of $11.45. The company’s market cap is $475.59 million.

Ignyta (NASDAQ:RXDX) last released its quarterly earnings results on Tuesday, August 8th. The biopharmaceutical company reported ($0.56) earnings per share for the quarter, beating the Zacks’ consensus estimate of ($0.63) by $0.07. Analysts anticipate that Ignyta, Inc. will post ($2.57) EPS for the current year.

TRADEMARK VIOLATION WARNING: “Algert Global LLC Invests $667,000 in Ignyta, Inc. (NASDAQ:RXDX)” was posted by Daily Political and is owned by of Daily Political. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at https://www.dailypolitical.com/2017/08/11/algert-global-llc-invests-667000-in-ignyta-inc-nasdaqrxdx.html.

A number of equities research analysts recently weighed in on RXDX shares. Cantor Fitzgerald restated a “buy” rating and set a $18.00 price objective on shares of Ignyta in a research report on Friday, April 28th. Zacks Investment Research lowered Ignyta from a “hold” rating to a “sell” rating in a research report on Wednesday, May 24th. ValuEngine upgraded Ignyta from a “sell” rating to a “hold” rating in a research report on Thursday, June 15th. Jefferies Group LLC restated a “buy” rating and set a $27.00 price objective on shares of Ignyta in a research report on Thursday, June 22nd. Finally, BidaskClub lowered Ignyta from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 19th. One research analyst has rated the stock with a sell rating, two have issued a hold rating and two have issued a buy rating to the company. The stock currently has a consensus rating of “Hold” and an average price target of $17.33.

About Ignyta

Ignyta, Inc is a biotechnology company. The Company is focused on precision medicine in oncology. The Company is pursuing an integrated therapeutic (Rx) and companion diagnostic (Dx) strategy for treating cancer patients. The Company’s pipeline includes various compounds, such as entrectinib, RXDX-105, taladegib and RXDX-106.

Want to see what other hedge funds are holding RXDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ignyta, Inc. (NASDAQ:RXDX).

Institutional Ownership by Quarter for Ignyta (NASDAQ:RXDX)

Receive News & Ratings for Ignyta Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ignyta Inc. and related companies with MarketBeat.com's FREE daily email newsletter.